Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

Healthcare Biotechnology
CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


TSXV:CVM.H - Post by User

CVR Medical Corp
Bullboard Posts
User Avatar Image
(20)
•••
Comment by OleMuleon Mar 16, 2020 4:00pm
75 Views
Post# 30814244

RE:RE:RE:TSX

RE:RE:RE:TSXGrowth - You have no ideas about the Exchange and the halt.  This does not help. The press release made it sound like they already have preliminary approval from the Exchange, they dont.   Its a mute point regardless as 55-60M shares will be voting against it IF it ever gets to a shareholder vote.  I'd ask all of you to ask the company to share the ENTIRE agreement with the shareholders, I doubt they share it.  I'd also ask for a complete list of the IP, as the former execs and Directors who led the investrment group saw/have it and from what I gather, it is in shambles so why would Medical need the Global IP that they claim is worth so much and issue all of that dilution?  Medical already owns the rights Globally for the CSS as it relates to stroke.  

Sorry to burst your bubbles, unfortunately this is not a GREAT press release or deal for stakeholders.  Its a great deal for Global but Global wont be able to vote and as i stated IF it EVER passes the TSX, the top holders will vote against, so its DOA. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities